» Articles » PMID: 36904081

To Fiber or Not to Fiber: The Swinging Pendulum of Fiber Supplementation in Patients with Inflammatory Bowel Disease

Overview
Journal Nutrients
Date 2023 Mar 11
PMID 36904081
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence-based dietary guidance around dietary fiber in inflammatory bowel disease (IBD) has been limited owing to insufficient reproducibility in intervention trials. However, the pendulum has swung because of our increased understanding of the importance of fibers in maintaining a health-associated microbiome. Preliminary evidence suggests that dietary fiber can alter the gut microbiome, improve IBD symptoms, balance inflammation, and enhance health-related quality of life. Therefore, it is now more vital than ever to examine how fiber could be used as a therapeutic strategy to manage and prevent disease relapse. At present, there is limited knowledge about which fibers are optimal and in what form and quantity they should be consumed to benefit patients with IBD. Additionally, individual microbiomes play a strong role in determining the outcomes and necessitate a more personalized nutritional approach to implementing dietary changes, as dietary fiber may not be as benign as once thought in a dysbiotic microbiome. This review describes dietary fibers and their mechanism of action within the microbiome, details novel fiber sources, including resistant starches and polyphenols, and concludes with potential future directions in fiber research, including the move toward precision nutrition.

Citing Articles

From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management.

Naik R, Purcell S, Gold S, Christiansen V, DAloisio L, Raman M Nutrients. 2025; 17(3).

PMID: 39940329 PMC: 11821149. DOI: 10.3390/nu17030470.


Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis.

Cosier D, Lambert K, Charlton K, Batterham M, Little R, Wu N Nutrients. 2025; 16(24).

PMID: 39770970 PMC: 11677955. DOI: 10.3390/nu16244349.


Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide.

Salvatore S, Battigaglia M, Murone E, Dozio E, Pensabene L, Agosti M Nutrients. 2023; 15(9).

PMID: 37432354 PMC: 10180776. DOI: 10.3390/nu15092208.

References
1.
Vanhauwaert E, Matthys C, Verdonck L, De Preter V . Low-residue and low-fiber diets in gastrointestinal disease management. Adv Nutr. 2015; 6(6):820-7. PMC: 4642427. DOI: 10.3945/an.115.009688. View

2.
Topping D, Fukushima M, Bird A . Resistant starch as a prebiotic and synbiotic: state of the art. Proc Nutr Soc. 2003; 62(1):171-6. DOI: 10.1079/pns2002224. View

3.
. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019; 5(1):17-30. PMC: 7026709. DOI: 10.1016/S2468-1253(19)30333-4. View

4.
Wu G, Zhao N, Zhang C, Lam Y, Zhao L . Guild-based analysis for understanding gut microbiome in human health and diseases. Genome Med. 2021; 13(1):22. PMC: 7874449. DOI: 10.1186/s13073-021-00840-y. View

5.
Montroy J, Berjawi R, Lalu M, Podolsky E, Peixoto C, Sahin L . The effects of resistant starches on inflammatory bowel disease in preclinical and clinical settings: a systematic review and meta-analysis. BMC Gastroenterol. 2020; 20(1):372. PMC: 7653724. DOI: 10.1186/s12876-020-01516-4. View